Depletion of dopamine in the striatum as an experimental model of parkinsonism: direct effects and adaptive mechanisms
暂无分享,去创建一个
[1] T. Nagatsu,et al. Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain. , 1977, Clinica chimica acta; international journal of clinical chemistry.
[2] S. Iversen,et al. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum , 1975, Brain Research.
[3] K. E. Moore,et al. Reversal of α‐methyltyrosine‐induced behavioural depression with dihydroxyphenylalanine and amphetamine , 1967, The Journal of pharmacy and pharmacology.
[4] E. Stricker,et al. Deficits in Feeding Behavior after Intraventricular Injection of 6-Hydroxydopamine in Rats , 1972, Science.
[5] G. Bernardi,et al. The action of dopamine on rat caudate neurones intracellularly recorded , 1978, Neuroscience Letters.
[6] U. Ungerstedt. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. , 1971, Acta physiologica Scandinavica. Supplementum.
[7] P. Maclean,et al. A brainstem atlas of catecholaminergic neurons and serotonergic perikarya in a pygmy primate (Cebuella pygmaea) , 1978, The Journal of comparative neurology.
[8] N. A. Buchwald,et al. The spontaneous firing pattern of forebrain neurons. I. The effects of dopamine and non-dopamine depleting lesions on caudate unit firing patterns. , 1974, Brain research.
[9] M. Garcia-Munoz,et al. Feedback loop or output pathway in striato-nigral fibres? , 1977, Nature.
[10] D. Albe-Fessard,et al. A study of an ascending nigro-caudate pathway. , 1972, Electroencephalography and clinical neurophysiology.
[11] F E Bloom,et al. Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. , 1978, Annual review of neuroscience.
[12] D. Purpura,et al. Electrophysiological analysis of reciprocal caudato-nigral relations. , 1967, Brain research.
[13] Y. Ben-Ari,et al. Dopamine evoked inhibition of single cells of the feline putamen and basolateral amygdala. , 1976, The Journal of physiology.
[14] K. E. Moore,et al. ALTERATIONS IN BEHAVIOR AND BRAIN CATECHOLAMINE LEVELS IN RATS TREATED WITH α-METHYLTYROSINE , 1966 .
[15] Y. Satoh,et al. Adenosine 3',5'-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra. , 1976, European journal of pharmacology.
[16] P. Teitelbaum,et al. The lateral hypothalamic syndrome: recovery of feeding and drinking after lateral hypothalamic lesions. , 1962, Psychological review.
[17] I. Creese. Behavioural evidence of dopamine receptor stimulation by piribedil (ET495) and its metabolite S584. , 1974, European journal of pharmacology.
[18] P. Riekkinen,et al. Dopaminergic nervous transmission in Parkinson's disease. , 1974, Medical biology.
[19] G. Mckenzie,et al. The effect of dihydroxyphenylalanine, pheniprazine and dextroamphetamine on the in vivo release of dopamine from the caudate nucleus. , 1968, The Journal of pharmacology and experimental therapeutics.
[20] A. Björklund,et al. Dopaminergic innervation of the globus pallidus by collaterals from the nigrostriatal pathway , 1979, Brain Research.
[21] T. Ljungberg,et al. Reinstatement of eating by dopamine agonists in aphagic dopamine denervated rats , 1976, Physiology & Behavior.
[22] Y. Agid,et al. Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat. , 1973, Nature: New biology.
[23] P. Spano,et al. Dopamine receptor sensitivity in brain and retina of rats during aging , 1977, Brain Research.
[24] M. Zigmond,et al. Glucoregulatory feeding by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions. , 1975, Science.
[25] O. Hornykiewicz,et al. ADENYLATE CYCLASE-COUPLED DOPAMINE RECEPTORS IN PARKINSON'S DISEASE , 1979 .
[26] P. Teitelbaum,et al. Somnolence, akinesia, and sensory activation of motivated behavior in the lateral hypothalamic syndrome. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. A. González-Vegas. Antagonism of dopamine-mediated inhibition in the nigro-striatal pathway: a mode of action of some catatonia-inducing drugs. , 1974, Brain research.
[28] P. Feltz,et al. Properties of caudate unitary responses to repetitive nigral stimulation. , 1969, Brain research.
[29] P. Cuatrecasas,et al. Immunohistochemical localization of enkephalin in rat brain and spinal cord , 1978, The Journal of comparative neurology.
[30] H. Fibiger,et al. Increased striatal glutamate decarboxylase after lesions of the nigrostriatal pathway , 1978, Brain Research.
[31] O. Hornykiewicz,et al. Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions , 1970, Science.
[32] U. Ungerstedt,et al. 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. , 1968, European journal of pharmacology.
[33] A. J. Harris,et al. The development of chemosensitivity in extrasynaptic areas of the neuronal surface after denervation of parasympathetic ganglion cells in the heart of the frog , 1971, Proceedings of the Royal Society of London. Series B. Biological Sciences.
[34] L. Butcher,et al. Origin and modulation of acetylcholine activity in the neostriatum. , 1974, Brain research.
[35] H. Fibiger,et al. Temporal changes in amine synthesizing enzymes of rat extrapyramidal structures after hemitransections or 6-hydroxydopamine administration. , 1973, Brain research.
[36] J. Rossum,et al. Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens , 1973, The Journal of pharmacy and pharmacology.
[37] G. Gessa,et al. Differential effect of psychotropic drugs on dihydroxyphenylacetic acid (DOPAC) in the rat substantia nigra and caudate nucleus. , 1977, Life sciences.
[38] P. Spano,et al. Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. , 1978, Life sciences.
[39] N. Uretsky,et al. Altered response to apomorphine in 6-hydroxydopamine-treated rats. , 1972, European journal of pharmacology.
[40] M. Sambrook,et al. Experimental torticollis in the monkey produced by unilateral 6-hydroxydopamine brain lesions , 1978, Brain Research.
[41] P. Kelly. Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats , 1975, Brain Research.
[42] O. Bugiani,et al. Nerve cell loss with aging in the putamen. , 1978, European neurology.
[43] L. Thal,et al. Evidence for selective loss of brain dopamine- and histamine-stimulated adenylate cyclase activities in rabbits with aging , 1980, Brain Research.
[44] T. Ljungberg,et al. Sensory inattention produced by 6-hydroxydopamine-induced degeneration of ascending dopamine neurons in the brain , 1976, Experimental Neurology.
[45] K. Jellinger,et al. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.
[46] N. Uretsky,et al. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats. , 1973, The Journal of pharmacology and experimental therapeutics.
[47] U. Ungerstedt,et al. Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model. , 1977, European journal of pharmacology.
[48] M. Zigmond,et al. ADAPTIVE NEUROCHEMICAL CHANGES FOLLOWING DESTRUCTION OF CENTRAL DOPAMINE-CONTAINING TERMINALS , 1979 .
[49] J. Kebabian,et al. Biochemical changes accompanying unilateral 6-hydroxydopamine lesions in the rat substantia nigra , 1978, Brain Research.
[50] L. Stein,et al. The distribution of enkephalin-immunoreactive cell bodies in the rat central nervous system , 1977, Neuroscience Letters.
[51] R. Roth,et al. Dopaminergic neurons--alteration in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow. , 1976, Biochemical pharmacology.
[52] D. Reis,et al. Reversible changes in the activities and amounts of tyrosine hydroxylase in dopamine neurons of the substantia nigra in response to axonal injury as studied by immunochemical and immunocytochemical methods , 1978, Brain Research.
[53] J. Marshall. Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: Spontaneous recovery and pharmacological control , 1979, Brain Research.
[54] L. Iversen,et al. Storage and synthesis of norepinephrine in the reserpine-treated rat brain. , 1966, The Journal of pharmacology and experimental therapeutics.
[55] U. Ungerstedt,et al. Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease. , 1971, European journal of pharmacology.
[56] W. Fratta,et al. Determination of methionine enkephalin in discrete regions of rat brain , 1977, Brain Research.
[57] R. Roth,et al. Dopaminergic neurons: Role of presynaptic receptors in the regulation of transmitter biosynthesis , 1978 .
[58] J D Connor,et al. Caudate nucleus neurones: correlation of the effects of substantia nigra stimulation with iontophoretic dopamine , 1970, The Journal of physiology.
[59] W. Mcbride,et al. Neurochemical changes following the administration of depleters of biogenic monoamines. , 1976, Life sciences.
[60] E. Bennett,et al. The influence of duration of protein synthesis inhibition on memory. , 1973, Physiology & behavior.
[61] L. Poirier. Experimental and histological study of midbrain dyskinesias. , 1960, Journal of neurophysiology.
[62] M Goldstein,et al. Immunohistochemical studies on the localization and distribution of monoamine neuron systems in the rat brain II. Tyrosine hydroxylase in the telencephalon. , 1977, Medical biology.
[63] U. Ungerstedt,et al. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour. , 1976, Pharmacology & therapeutics. Part B: General & systematic pharmacology.
[64] P. Mcgeer,et al. Immunohistochemical localization of choline acetyltransferase containing neostriatal neurons and their relationship with dopaminergic synapses , 1976, Brain Research.
[65] B. Cooper,et al. Alterations in consummatory behavior following intracisternal injection of 6-hydroxydopamine. , 1973, Pharmacology, biochemistry, and behavior.
[66] P. Mcgeer,et al. Influence of noncholinergic drugs on rat striatal acetylcholine levels. , 1974, Brain research.
[67] A. Randrup,et al. Role of Catecholamines in the Amphetamine Excitatory Response , 1966, Nature.
[68] H. Fibiger,et al. Neostriatal choline acetylase and cholinesterase following selective brain lesions. , 1971, Brain research.
[69] B J Hoffer,et al. Cytochemical and electrophysiological studies of dopamine in the caudate nucleus. , 1976, Research publications - Association for Research in Nervous and Mental Disease.
[70] P. Seeman,et al. Brain neurotransmitter receptors after long-term haloperidol: dopamine, acetylcholine, serotonin, alpha-noradrenergic and naloxone receptors. , 1977, Life sciences.
[71] H. Fibiger,et al. Altered neurotransmitter synthetic enzyme activity in some extrapyramidal nuclei after lesions of the nigro-striatal dopamine projection. , 1978, Life sciences.
[72] N. Andén,et al. A quantitative study on the nigro-neostriatal dopamine neuron system in the rat. , 1966, Acta physiologica Scandinavica.
[73] J. Petajan,et al. Motor unit control in Parkinson's disease and the influence of levodopa , 1975, Neurology.
[74] K. E. Moore,et al. Development of tolerance to the behavioural depressant effects of α‐methyltyrosine , 1968 .
[75] D. E. Blake,et al. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat. , 1972, The Journal of pharmacology and experimental therapeutics.
[76] O. Hornykiewicz,et al. The neurochemistry of Parkinson's disease: effect of L-dopa therapy. , 1975, The Journal of pharmacology and experimental therapeutics.
[77] A. Phillips,et al. Regulatory deficits after unilateral electrolytic or 6-OHDA lesions of the substantia nigra. , 1973, American Journal of Physiology.
[78] S. Symchowicz,et al. Inhibition of dopamine uptake into synaptosomes of rat corpus striatum by chlorpheniramine and its structural analogs. , 1971, Life sciences. Pt. 1: Physiology and pharmacology.
[79] Y. Wong,et al. Chemical lesion and drug induced supersensitivity and subsensitivity of caudate dopamine receptors. , 1978, Life sciences.
[80] P. Randall,et al. Body weight and regulatory deficits following unilateral nigrostriatal lesions , 1977, Brain Research.
[81] G. Paxinos,et al. Evidence for a long Leu-enkephalin striopallidal pathway in rat brain , 1978, Nature.
[82] R. Wurtman,et al. The site of dopamine formation in rat striatum after L-dopa administration. , 1981, The Journal of pharmacology and experimental therapeutics.
[83] M. Sanghera,et al. Effects of severe dopamine depletion on dopamine neuronal impulse flow and on tyrosine hydroxylase regulation , 1981, Brain Research Bulletin.
[84] John F. Marshall,et al. Plasticity of [14C]2-deoxy-d-glucose incorporation into neostriatum and related structures in response to dopamine neuron damage and apomorphine replacement , 1980, Brain Research.
[85] S. Iversen,et al. Effects of 6-Hydroxydopamine on CNS Catecholamines, Spontaneous Motor Activity and Amphetamine Induced Hyperactivity in Rats , 1970, Nature.
[86] E. Stricker,et al. The lateral hypothalamic syndome: comparison with the syndrome of anorexia nervosa. , 1980, Life sciences.
[87] S. Halvorsen,et al. EFFECTS OF HYPOTHALAMIC LESIONS ON THE ERYTHROPOIETIC RESPONSE TO HYPOXIA IN RABBITS. , 1964, Acta physiologica Scandinavica.
[88] K. E. Moore,et al. Blockade of alpha-methyltyrosine-induced supersensitivity to apomorphine by chronic administration of L-dopa. , 1975, Life sciences.
[89] T. Ljungberg,et al. Dopaminergic supersensitivity in the striatum. , 1975, Advances in neurology.
[90] T. Svensson,et al. On the mode of action of amantadine , 1970, The Journal of pharmacy and pharmacology.
[91] M. Filion. Effects of interruption of the nigrostriatal pathway and of dopaminergic agents on the spontaneous activity of globus pallidus neurons in the awake monkey , 1979, Brain Research.
[92] R. Wurtman,et al. Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization , 1980, Brain Research.
[93] C. Finch,et al. Catecholamine metabolism in the brains of ageing male mice. , 1973, Brain research.
[94] C. Gauchy,et al. The in vivo release of acetylcholine from cat caudate nucleus after pharmacological and surgical manipulations of dopaminergic nigrostriatal neurons. , 1973, Brain research.
[95] J. Hyttel,et al. Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro. , 1978, Life sciences.
[96] P. Greengard,et al. Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[97] P. Vonvoigtlander,et al. Increased sensitivity to dopaminergic agents after chronic neuroleptic treatment. , 1975, The Journal of pharmacology and experimental therapeutics.
[98] P. Bédard,et al. The role of D-1 and D-2 receptors , 1980, Nature.
[99] R. Miledi. The acetylcholine sensitivity of frog muscle fibres after complete or partial denervation , 1960, The Journal of Physiology.
[100] G. Sedvall,et al. The rate of norepinephrine synthesis measured in vivo during short intervals; influence of adrenergic nerve impulse activity. , 1968, The Journal of pharmacology and experimental therapeutics.
[101] J. Waddington,et al. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum. , 1979, European journal of pharmacology.
[102] L. Iversen. Dopamine receptors in the brain. , 1975, Science.
[103] Philip M. Groves,et al. Dopamine receptor changes following destruction of the nigrostriatal pathway: Lack of a relationship to rotational behavior , 1981, Brain Research.
[104] G. Steg. EFFERENT MUSCLE INNERVATION AND RIGIDITY. , 1964, Acta physiologica Scandinavica. Supplementum.
[105] A. Dallob,et al. The effect of long-term lithium treatment on reserpine-induced supersensitivity in dopaminergic and serotonergic transmission. , 1979, Life sciences.
[106] M. Baudry,et al. Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitors. , 1977, Life sciences.
[107] K. E. Moore,et al. Mesolimbic dopaminergic neurones in the rotational model of nigrostriatal function , 1976, Nature.
[108] K. Fuxe,et al. CHANGES IN THE DEVELOPMENT OF CENTRAL NOR ADRENALINE NEURONES FOLLOWING NEONATAL ADMINISTRATION OF 6‐HYDROXYDOPAMINE 1 , 1974, Journal of neurochemistry.
[109] M. Makman,et al. Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3':5'-cyclic monophosphate formation in intact retina. , 1972, Proceedings of the National Academy of Sciences of the United States of America.
[110] U. Ungerstedt,et al. Evidence for a new type of dopamine receptor stimulating agent , 1971, The Journal of pharmacy and pharmacology.
[111] S. Snyder,et al. An endogenous morphine-like factor in mammalian brain. , 1975, Life sciences.
[112] J. Leysen,et al. Apomorphine: chemistry, pharmacology, biochemistry. , 1976, International review of neurobiology.
[113] P. Bédard,et al. Correlative neuroanatomical and neuropharmacological study of tremor and catatonia in the monkey. , 1971, Neuropharmacology.
[114] H. Fibiger,et al. Neurochemical evidence for denervation supersensitivity: the effect of unilateral substantia nigra lesions on apomorphine-induced increases in neostriatal acetylcholine levels. , 1974, Life sciences.
[115] R. Faull,et al. Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra. , 1969, Experimental neurology.
[116] J. Marshall,et al. Movement disorders of aged rats: reversal by dopamine receptor stimulation. , 1979, Science.
[117] M. Baudry,et al. Long-term changes in the sensitivity of pre- and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies , 1977, Brain Research.
[118] F. Ledda,et al. Reversal by 3,4-dihydroxyphenylalanine of reserpine-induced regional changes in acetylcholine content in guinea-pig brain. , 1966, Biochemical pharmacology.
[119] T. Hökfelt,et al. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis. , 1978, Federation proceedings.
[120] S. Berl,et al. Effect of reserpine on the turnover of glutamate, glutamine, aspartate and GABA labeled with [1-14C]acetate in caudate nucleus, thalamus and sensorimotor cortex(cat). , 1969, Brain research.
[121] G. Yarbrough. Supersensitivity of caudate neurones after repeated administration of haloperidol. , 1975, European journal of pharmacology.
[122] C. Marsden,et al. Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months , 1979, Nature.
[123] A. Carlsson,et al. Evidence for a receptor‐mediated feedback control of striatal tyrosine hydroxylase activity , 1972, The Journal of pharmacy and pharmacology.
[124] P. Herrling,et al. Iontophoretically applied dopamine depolarizes and hyperpolarizes the membrane of cat caudate neurons , 1980, Brain Research.
[125] R. Katzman.,et al. Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[126] S. Snyder,et al. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding. , 1979, European journal of pharmacology.
[127] J. Kebabian,et al. Multiple receptors for dopamine , 1979, Nature.
[128] J. Bureš,et al. Asymmetry of EEG arousal in rats with unilateral 6-hydroxydopamine lesions of substantia nigra: Quantification of neglect , 1978, Experimental Neurology.
[129] K. E. Moore,et al. A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice. , 1974, Neuropharmacology.
[130] L. Volicer,et al. Effect of aging on cyclic AMP levels and adenylate cyclase and phosphodiesterase activities in the rat corpus striatum , 1977, Mechanisms of Ageing and Development.
[131] P. Mcgeer,et al. ENZYMES ASSOCIATED WITH THE METABOLISM OF CATECHOLAMINES, ACETYLCHOLINE AND GABA IN HUMAN CONTROLS AND PATIENTS WITH PARKINSON'S DISEASE AND HUNTINGTON'S CHOREA , 1976, Journal of neurochemistry.
[132] J. de Champlain,et al. Enhanced sensitivity of caudate neurones to microiontophoretic injections of dopamine in 6-hydroxydopamine treated cats. , 1972, Brain research.
[133] T. Nagatsu,et al. Dopamine-stimulated adenylate cyclase activity in the human brain: changes in Parkinsonism. , 1978, Biochemical medicine.
[134] S. Snyder,et al. The regional distribution of a morphine-like factor enkephalin in monkey brain , 1976, Brain Research.
[135] H. Fibiger,et al. Ascending projections of presumed dopamine-containing neurons in the ventral tegmentum of the rat as demonstrated by horseradish peroxidase , 1977, Neuroscience.
[136] H. Mclennan,et al. Mechanisms of excitation and inhibition in the nigrostriatal system , 1977, Brain Research.
[137] L. Thal,et al. Evidence for loss of brain [3H]spiroperidol and [3H]ADTN binding sites in rabbit brain with aging , 1980, Brain Research.
[138] J. Marshall,et al. Sensory inattention in rats with 6-hydroxydopamine-induced degeneration of ascending dopaminergic neurons: Apomorphine-induced reversal of deficits , 1979, Experimental Neurology.
[139] K. E. Moore,et al. Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants. , 1973, Neuropharmacology.
[140] N. Andén,et al. Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum☆ , 1964 .
[141] P. A. Shore,et al. The reserpine receptor. , 1978, Life sciences.
[142] J. Waddington,et al. Denervation supersensitivity in the striatonigral GABA pathway , 1978, Nature.
[143] P. Mcgeer,et al. Aging and extrapyramidal function. , 1977, Archives of neurology.
[144] R. Roth,et al. Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. , 1976, European journal of pharmacology.
[145] G. Scatchard,et al. THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .
[146] S. Snyder,et al. Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. , 1977, Science.
[147] A. Ward,et al. Neuronal hyperactivity in experimental trigeminal deafferentation. , 1971, Journal of neurosurgery.
[148] P. Bédard,et al. The rubro-olivo-cerebello-rubral loop and postural tremor in the monkey. , 1970, Journal of the neurological sciences.
[149] H. J. Spencer,et al. Alterations by anesthetic agents of the responses of rat striatal neurons to iontophoretically applied amphetamine, acetylcholine, noradrenaline, and dopamine. , 1974, Canadian journal of physiology and pharmacology.
[150] W. Schultz,et al. Striatal cell supersensitivity to apomorphine in dopamine-lesioned rats correlated to behaviour , 1978, Neuropharmacology.
[151] The spontaneous firing patterns of forebrain neurons. V. Time course of changes in caudate unit activity following dopamine-depleting lesions , 1980, Brain Research.
[152] R. Wampler. Regulatory deficits in rats following unilateral lesions of the lateral hypothalamus. , 1971, Journal of comparative and physiological psychology.
[153] K. Fuxe,et al. Functional role of the nigro-neostriatal dopamine neurons. , 2009, Acta pharmacologica et toxicologica.
[154] P. Teitelbaum,et al. Nigrostriatal bundle damage and the lateral hypothalamic syndrome. , 1974, Journal of comparative and physiological psychology.
[155] Edward V. Evarts,et al. PATHOPHYSIOLOGY OF MOTOR PERFORMANCE IN PARKINSON'S DISEASE , 1979 .
[156] K. Fuxe,et al. Tremor and Involuntary Movements in Monkeys: Effect of L-Dopa and of a Dopamine Receptor Stimulating Agent , 1973, Science.
[157] J. Hubbard,et al. Fluorescence histochemistry of monoamine‐containing cell bodies in the brain stem of the squirrel monkey (Saimiri sciureus). IV. An atlas , 1973, The Journal of comparative neurology.
[158] B. Berger,et al. Histochemical confirmation for dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathways. , 1974, Brain research.
[159] G. Stern. The effects of lesions in the substantia nigra. , 1966, Brain : a journal of neurology.
[160] A. Weissman,et al. Behavioral effects of L-α-methyltyrosine, an inhibitor of tyrosine hydroxylase , 1965 .
[161] S. Snyder,et al. Dopamine receptor binding in the corpus striatum of mammalian brain. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[162] W. F. Windle,et al. Functional and Structural Observations on Chronically Reserpinized Monkeys , 1958 .
[163] S J Young,et al. Self-inhibition by dopaminergic neurons , 1975, Science.
[164] E. Evarts. Pyramidal tract activity associated with a conditioned hand movement in the monkey. , 1966, Journal of neurophysiology.
[165] R. Wurtman,et al. Dopaminergic neurons in the nigro-striatal and mesolimbic pathways: mediation of specific effects of D-amphetamine. , 1975, European journal of pharmacology.
[166] E. Garcia-Rill,et al. The spontaneous firing patterns of forebrain neurons. III. Prevention of induced asymmetries in caudate neuronal firing rates by unilateral thalamic lesions , 1977, Brain Research.
[167] D. Reis,et al. Collateral sprouting in central mesolimbic dopamine neurons: Biochemical and immunocytochemical evidence of changes in the activity and distribution of tyrosine hydroxylase in terminal fields and in cell bodies of A10 neurons , 1979, Brain Research.
[168] N. Andén,et al. Effect of local application of apomorphine to the corpus striatum and to the nucleus accumbens on the reserpine-induced rigidity in rats , 1977, Brain Research.
[169] H. Fibiger,et al. Aging and brain enzymes. , 1971, Experimental gerontology.
[170] L. Thal,et al. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes , 1979, Brain Research.
[171] R. Baldessarini,et al. Pathophysiologic basis of tardive dyskinesia. , 1977, Advances in biochemical psychopharmacology.
[172] T. Hökfelt,et al. Evidence for dopamine receptor stimulation by apomorphine , 1967, The Journal of pharmacy and pharmacology.
[173] A. Ward,et al. Some effects of deafferentation on neurons of the cat spinal cord. , 1967, Archives of neurology.
[174] B. Costall,et al. Non-specific supersensitivity of striatal dopamine receptors after 6-hydroxydopamine lesion of the nigrostriatal pathway. , 1976, European journal of pharmacology.
[175] U. Ungerstedt,et al. Striatal efferent fibers play a role in maintaining rotational behavior in the rat , 1977, Science.
[176] H. Fibiger,et al. Early behavioural effects of intraventricular administration of 6-hydroxydopamine in rat. , 1972, Nature: New biology.
[177] U. Ungerstedt,et al. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.
[178] R. E. Berger,et al. Age-related changes in the nigrostriatum: a behavioral and biochemical analysis. , 1978, Journal of gerontology.
[179] C. Bradshaw,et al. EFFECTS OF DESIPRAMINE ON NEURONAL RESPONSES TO DOPAMINE, NORADRENALINE, 5‐HYDROXYTRYPTAMINE AND ACETYLCHOLINE IN THE CAUDATE NUCLEUS OF THE RAT , 1975, British journal of pharmacology.
[180] R. Wise,et al. Retrograde fluorescent tracing of substantia nigra neurons combined with catecholamine histofluorescence , 1980, Brain Research.
[181] U. Ungerstedt,et al. High correlations between number of dopamine cells, dopamine levels and motor performance , 1977, Brain Research.
[182] S. Iversen,et al. Amphetamine response in rat after dopamine neurone destruction. , 1972, Nature: New biology.
[183] P. Teitelbaum,et al. Further analysis of sensory inattention following lateral hypothalamic damage in rats. , 1974, Journal of comparative and physiological psychology.
[184] O. Hornykiewicz. Dopamine (3-hydroxytyramine) and brain function. , 1966, Pharmacological reviews.
[185] R. Baldessarini,et al. Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. , 1974, Neuropharmacology.
[186] E. Stricker,et al. Activation-induced restoration of sensorimotor functions in rats with dopamine-depleting brain lesions. , 1976, Journal of comparative and physiological psychology.
[187] C. Finch,et al. The Regulation of Physiological Changes During Mammalian Aging , 1976, The Quarterly Review of Biology.
[188] M. Zigmond,et al. Recovery of Feeding and Drinking by Rats after Intraventricular 6-Hydroxydopamine or Lateral Hypothalamic Lesions , 1973, Science.
[189] B. Waldeck,et al. A Mg-ATP dependent storage mechanism in the amine granules of the adrenal medulla. , 1962, Medicina experimentalis : International journal of experimental medicine.
[190] H. Mclennan,et al. The action of dopamine on neurones of the caudate nucleus , 1967, The Journal of physiology.
[191] P. Bédard,et al. Reversible effect of L-dopa on tremor and catatonia induced by alpha-methyl-p-tyrosine. , 1970, Canadian journal of physiology and pharmacology.
[192] H. Fibiger,et al. Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: similarities to the lateral hypothalamic syndrome. , 1973, Brain research.
[193] T. Hökfelt,et al. Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system. , 1973, Brain research.
[194] S. Iversen,et al. The pharmacological and anatomical substrates of the amphetamine response in the rat , 1975, Brain Research.
[195] I. Jurna. Striatal monoamines and reserpine and chlorpromazine rigidity. , 1976, Pharmacology & therapeutics. Part B: General & systematic pharmacology.
[196] M. Lindqvist,et al. BRAIN MONOAMINE LEVELS AND BEHAVIOUR DURING LONG-TERM ADMINISTRATION OF RESERPINE. , 1964, International journal of neuropharmacology.
[197] L. Iversen,et al. Time course of the effects of 6‐hydroxydopamine on catecholamine‐containing neurones in rat hypothalamus and striatum , 1970, British journal of pharmacology.
[198] U. Thendelenburg. I. MECHANISMS OF SUPERSENSITIVITY AND SUBSENSITIVITY TO SYMPATHOMIMETIC AMINES , 1966 .
[199] H. Fibiger,et al. Apomorphine and amphetamine stereotypy after 6-hydroxydopamine lesions of the substantia nigra. , 1974, European journal of pharmacology.
[200] P. Mcgeer,et al. Evidence on the cellular localization of adenyl cyclase in the neostriatum , 1976, Brain Research.
[201] R. Roth,et al. Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. , 1973, The Journal of pharmacology and experimental therapeutics.
[202] O. Hornykiewicz,et al. L-Glutamic Acid Decarboxylase in Parkinson's Disease: Effect of L-Dopa Therapy , 1973, Nature.
[203] K. E. Moore,et al. BEHAVIORAL EFFECTS OF α-METHYLTYROSINE AFTER PRIOR DEPLETION OF BRAIN CATECHOLAMINES , 1968 .
[204] M. Vogt,et al. DEPRESSION BY RESERPINE OF THE NORADRENALINE CONCENTRATION IN THE HYPOTHALAMUS OF THE CAT , 1956, Journal of neurochemistry.
[205] P. Spano,et al. [3H]Haloperidol and [3H]spiroperidol binding in rat striatum during ageing , 1978, The Journal of pharmacy and pharmacology.
[206] H. Fibiger,et al. Analysis of the fine structure of the dopaminergic nigrostriatal projection by electron microscopic autoradiography. , 1973, Experimental neurology.
[207] R. Spehlmann. The effects of acetylcholine and dopamine on the caudate nucleus depleted of biogenic amines. , 1975, Brain : a journal of neurology.
[208] B. Sahakian,et al. Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPA , 1980, Pharmacology Biochemistry and Behavior.
[209] L. Olson,et al. Extraneuronal binding of catecholamines and 3,4-dihydroxyphenylalanine (dopa) in salivary glands. , 1967, Acta physiologica Scandinavica.
[210] J. C. Péchadre,et al. Parkinsonian akinesia, rigidity and tremor in the monkey Histopathological and neuropharmacological study , 1976, Journal of the Neurological Sciences.
[211] H. Fibiger,et al. Direct evidence for presynaptic and postsynaptic dopamine receptors in brain , 1978, Nature.
[212] P. Tongroach,et al. Neuropharmacological studies on the nigro-striatal and raphe-striatal system in the rat. , 1978, European journal of pharmacology.
[213] Goldberg Rm. Aphagia and adipsia produced by unilateral hypothalamic lesions in rats. , 1966 .
[214] T L Sourkes,et al. Striatal amines, experimental tremor and the effect of harmaline in the monkey. , 1966, Brain : a journal of neurology.
[215] J. Rotrosen,et al. Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats. , 1975, Life sciences.
[216] P. Teitelbaum,et al. Sensory Neglect Produced by Lateral Hypothalamic Damage , 1971, Science.
[217] J. Korf,et al. Enhanced dopamine metabolism after small lesions in the midbrain of the rat. , 1978, Life sciences.
[218] R. Mishra,et al. Supersensitivity in rat caudate nucleus: Effects of 6-hydroxydopamine on the time course of dopamine receptor and cyclic AMP changes , 1980, Brain Research.
[219] M. Goldstein,et al. STUDIES OF AMINES IN THE STRIATUM IN MONKEYS WITH NIGRAL LESIONS , 1969, Journal of neurochemistry.
[220] K. E. Moore,et al. Effects of α-methyltyrosine on brain catecholamines and conditioned behavior in guinea pigs , 1966 .
[221] S. Iversen,et al. Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. , 1973, Brain research.
[222] J. Coyle,et al. Striatal lesions with kainic acid: neurochemical characteristics , 1977, Brain Research.
[223] A. Heller,et al. Anatomical and chemical studies of a nigro-neostriatal projection in the cat. , 1971, Brain research.
[224] U. Ungerstedt. Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.
[225] P. Feltz. Sensitivity to haloperidol of caudate neurones excited by nigral stimulation. , 1971, European journal of pharmacology.
[226] J. Axelrod. THE METABOLISM, STORAGE, AND RELEASE OF CATECHOLAMINES. , 1965, Recent progress in hormone research.
[227] S. Snyder,et al. Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. , 1977, Science.
[228] W. McCulloch,et al. Production of an alternating tremor at rest in monkeys. , 1948, Journal of neurophysiology.
[229] S H Snyder,et al. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs , 1976, Science.
[230] R. Duvoisin,et al. The relationship between loss of dopamine nerve terminals, striatal [3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats , 1981, Brain Research.
[231] H. Loh,et al. Circling behavior in rats with 6-hydroxydopamine or electrolytic nigral lesions,. , 1976, European journal of pharmacology.
[232] S. Snyder,et al. Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates. , 1969, The Journal of pharmacology and experimental therapeutics.
[233] T. Ho¨kfelt,et al. Retrograde peroxidase tracing of neurons combined with transmitter histochemistry , 1975, Brain Research.
[234] R. Spehlmann,et al. Selective blockade of excitatory caudate responses to nigral stimulation by microiontophoretic application of dopamine antagonists , 1977, Neuroscience Letters.
[235] J. Loeser,et al. Neuronal hyperactivity following deafferentation of the lateral cuneate nucleus. , 1973, Experimental neurology.
[236] J. Stolk,et al. Enhanced stimulant effects of d-amphetamine in rats treated chronically with reserpine. , 1968, The Journal of pharmacology and experimental therapeutics.
[237] T. Stone,et al. Responses of central neurones to amantadine: comparison with dopamine and amphetamine , 1975, Brain Research.
[238] T. Sourkes,et al. Homovanillic acid and dihydroxyphenylacetic acid in the striatum of monkeys with brain lesions. , 1967, Canadian journal of physiology and pharmacology.
[239] B. Bioulac,et al. Responses of central neurones to piribedil and 2-bromo-alpha-ergocryptine: comparison with dopamine and apomorphine. , 1978, European journal of pharmacology.
[240] S. Iversen. The effect of surgical lesions to frontal cortex and substantia nigra on amphetamine responses in rats. , 1971, Brain research.
[241] R. Butterworth,et al. Hypokinesia produced by anterolateral hypothalamic 6-hydroxydopamine lesions and its reversal by some antiparkinson drugs , 1978, Pharmacology Biochemistry and Behavior.
[242] J. Fields,et al. Neurotransmitter receptor alterations in Parkinson's disease. , 1977, Life sciences.
[243] S. Snyder,et al. Dopamine receptors localised on cerebral cortical afferents to rat corpus striatum , 1978, Nature.
[244] N. Dafny. Electrophysiological properties of caudate neurons following substantia nigra, motor cortex, and amygdaloid nuclear complex stimulation of the rat. , 1975, Applied neurophysiology.
[245] R. Iansek. The effects of reserpine on motor activity and pallidal discharge in monkeys: implications for the genesis of akinesia , 1980, The Journal of physiology.
[246] T. Sourkes,et al. INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM. , 1965, Brain : a journal of neurology.
[247] C. Ohye,et al. Spontaneous activity of the putamen after chronic interruption of the dopaminergic pathway: effect of L-dopa. , 1970, The Journal of pharmacology and experimental therapeutics.
[248] N. Uretsky,et al. EFFECTS OF 6‐HYDROXYDOPAMINE ON CATECHOLAMINE CONTAINING NEURONES IN THE RAT BRAIN , 1970, Journal of neurochemistry.
[249] W. Precht,et al. Nigro-caudate and caudato-nigral relationship: an electrophysiological study , 1975, Brain Research.
[250] K. Jellinger,et al. CNS AND ADRENAL GLAND TYROSINE HYDROXYLASE AND THE INFLUENCE OF DRUG TREATMENT ON cAMP - ACTIVITY IN PARKINSON'S DISEASE - HUMAN POST MORTEM STUDIES , 1979 .
[251] C. Finch,et al. Reduced dopaminergic binding during aging in the rodent striatum , 1980, Brain Research.
[252] K. Fuxe,et al. DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS. , 1964, Life sciences.
[253] R. George,et al. Subcellular localization of dopamine-sensitive adenylate cyclase and dopamine receptor binding activities. , 1978, Life sciences.
[254] P. Spano,et al. Differential effect of reserpine on dopaminergic receptor function in rat substantia nigra and caudate nucleus , 1979, Brain Research.
[255] U. Ungerstedt. Stereotaxic mapping of the monoamine pathways in the rat brain. , 1971, Acta physiologica Scandinavica. Supplementum.
[256] N. Uretsky,et al. Effect of L-dopa on the locomotor activity of rats pretreated with 6-hydroxydopamine. , 1971, Nature: New biology.
[257] R. Baldessarini,et al. Pharmacologically induced behavioural supersensitivity to apomorphine. , 1973, Nature: New biology.
[258] J. Harvey,et al. LH syndrome and brain catecholamine levels after lesions of the nigrostriatal bundle. , 1972, Physiology & behavior.
[259] P. Greengard,et al. Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway. , 1976, Molecular pharmacology.
[260] A. Karczmar,et al. Effects of L-dopa on behavior and on brain amines in mice treated with 6-hydroxydopamine. , 1973, Pharmacology, biochemistry, and behavior.
[261] U. Ungerstedt,et al. Electrophysiological evidence for involvement of cyclic adenosine monophosphate in dopamine responses of caudate neurons , 1974 .
[262] G. Johnson,et al. Dopaminergic denervation supersensitivity and dopamine stimulated adenyl cyclase activity. , 1973, Neuropharmacology.
[263] R. Roth,et al. Dopamine neurons: role of impulse flow and presynaptic receptors in the regulation of tyrosine hydroxylase. , 1975, Psychopharmacology bulletin.
[264] J. Macon. Deafferentation hyperactivity in the monkey spinal trigeminal nucleus: neuronal responses to amino acid iontophoresis , 1979, Brain Research.
[265] K. Fuxe,et al. Rotational behaviour in rats with unilateral striatal kainic acid lesions: A behavioural model for studies on intact dopamine receptors , 1979, Brain Research.
[266] A. Carlsson,et al. 3,4-Dihydroxyphenylalanine and 5-Hydroxytryptophan as Reserpine Antagonists , 1957, Nature.
[267] A. Nieoullon,et al. Bradykinesia following unilateral lesions restricted to the substantia nigra in the baboon , 1981, Neuroscience Letters.
[268] F. Bloom,et al. Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis. , 1965, The Journal of pharmacology and experimental therapeutics.
[269] A. Sjoerdsma,et al. BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE, AN INHIBITOR OF TYROSINE HYDROXYLASE. , 1965, The Journal of pharmacology and experimental therapeutics.
[270] T. Williams,et al. Effect of dopamine on firing patterns of striatal units in adult and 21-day-old rats , 1977, Experimental Neurology.
[271] O. Hornykiewicz,et al. Receptor basis for dopaminergic supersensitivity in Parkinson's disease , 1978, Nature.
[272] K. Lloyd,et al. DISTRIBUTION OF CHOLINE ACETYLTRANSFERASE AND GLUTAMATE DECARBOXYLASE WITHIN THE SUBSTANTIA NIGRA AND IN OTHER BRAIN REGIONS FROM CONTROL AND PARKINSONIAN PATIENTS , 1975, Journal of neurochemistry.
[273] R. Spehlmann,et al. Decreased sensitivity of caudal neurons to microiontophoretic dopamine in dopamine-depleted caudate nucleus , 1978, Brain Research.
[274] A. Björklund,et al. Evidence for regenerative axon sprouting of central catecholamine neurons in the rat mesencephalon following electrolytic lesions. , 1971, Brain research.
[275] A. Carlsson,et al. Effect of Reserpine on Monoamine Synthesis and on Apparent Dopaminergic Receptor Sensitivity in Rat Brain , 1978 .
[276] R. Roth,et al. Effect of impulse flow on the release and synthesis of dopamine in the striatum , 1973 .
[277] P. Kelly,et al. Specificity of 6-hydroxydopamine-induced destruction of mesolimbic or nigrostriatal dopamine-containing terminals , 1977, Brain Research.
[278] P. Gaspar,et al. Regional Distribution of Neurotransmitter Synthesizing Enzymes in the Basal Ganglia of Human Brain , 1980, Journal of neurochemistry.
[279] D. Garver,et al. Monoamine distribution in primate brain. I. Catecholamine‐containing perikarya in the brain stem of Macaca speciosa , 1975, The Journal of comparative neurology.
[280] W. Fratta,et al. INTERACTIONS OF ENKEPHALINERGIC AND CATECHOLAMINERGIC NEURONS IN CNS AND PERIPHERY , 1979 .
[281] G Jonsson,et al. Chemical neurotoxins as denervation tools in neurobiology. , 1980, Annual review of neuroscience.
[282] M. Besson,et al. Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment. , 1970, European journal of pharmacology.
[283] U. Ungerstedt,et al. Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. , 1971, European journal of pharmacology.
[284] M. Carpenter,et al. Monoamine-containing cell bodies in the squirrel monkey brain. , 1974, The American journal of anatomy.
[285] G. Bernardi,et al. Intracellular responses of caudate neurons to brain stem stimulation. , 1970, Brain research.
[286] C. Marsden,et al. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain , 1976, Brain Research.
[287] Å. Bertler. Effect of Reserpine on the Storage of Catechol Amines in Brain and Other Tissues , 1961 .
[288] S. Kaufman,et al. The role of tetrahydropteridines in the enzymatic conversion of tyrosine to 3,4-dihydroxyphenylalanine , 1964 .
[289] F. Owen,et al. Characteristics of 3H-cis-flupenthixol binding to calf brain membranes. , 1980, European journal of pharmacology.
[290] K. E. Moore,et al. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice. , 1975, The Journal of pharmacology and experimental therapeutics.
[291] M. Zigmond,et al. Effects on homeostasis of intraventricular injections of 6-hydroxydopamine in rats. , 1974, Journal of comparative and physiological psychology.
[292] L. Descarries,et al. Dopaminergic nerve endings visualised by high-resolution autoradiography in adult rat neostriatum , 1980, Nature.
[293] W. Precht,et al. Blockage of caudate-evoked inhibition of neurons in the substantia nigra by picrotoxin. , 1971, Brain research.
[294] J. P. Walker,et al. Properties of adenylate cyclase from senescent rat brain. , 1973, Brain research.
[295] P. Seeman,et al. Antipsychotic drug doses and neuroleptic/dopamine receptors , 1976, Nature.
[296] T. Ljungberg,et al. Apomorphine-induced locomotion and gnawing: evidence that the experimental design greatly influences gnawing while locomotion remains unchanged. , 1977, European journal of pharmacology.
[297] J. Mcphillips,et al. Postjunctional supersensitivity and subsensitivity of excitable tissues to drugs. , 1973, Ergebnisse der Physiologie, biologischen Chemie und experimentellen Pharmakologie.
[298] L. Iversen,et al. Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum. , 1976, Molecular pharmacology.
[299] R. Romo,et al. Production and suppression of tremor by mesencephalic tegmental lesions in monkeys , 1979, Experimental Neurology.
[300] A. Carlsson,et al. Regulation of monoamine metabolism in the central nervous system. , 1972, Pharmacological reviews.
[301] N. A. Buchwald,et al. Caudate intracellular response to thalamic and cortical inputs. , 1973, Experimental neurology.
[302] P. Seeman,et al. Brain receptors for antipsychotic drugs and dopamine: direct binding assays. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[303] B. Berger,et al. Collateral sprouting and reduced activity of the rat mesocortical dopaminergic neurons after selective destruction of the ascending noradrenergic bundles , 1979, Neuroscience.
[304] S. Udenfriend,et al. TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS. , 1964, The Journal of biological chemistry.
[305] Sharpless Sk,et al. Supersensitivity-like phenomena in the central nervous system. , 1975 .
[306] N. Tsukahara,et al. Electrophysiological study of formation of new synapses and collateral sprouting in red nucleus neurons after partial denervation. , 1975, Journal of neurophysiology.
[307] G. Steg,et al. THE EFFECT OF L-3, 4-DIHYDROXYPHENYLALANINE AND DL-5-HYDROXYTRYPTOPHAN ON RIGIDITY AND TREMOR INDUCED BY RESERPINE, CHLORPROMAZINE AND PHENOXYBENZAMINE. , 1964, Life sciences.